AST
Asterias Biotherapeutics Inc. Series A
AST
AST
Delisted
AST was delisted on the 7th of March, 2019.
72 hedge funds and large institutions have $15.9M invested in Asterias Biotherapeutics Inc. Series A in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
38% less capital invested
Capital invested by funds: $25.5M → $15.9M (-$9.65M)
55% less call options, than puts
Call options by funds: $106K | Put options by funds: $233K
Holders
72
Holding in Top 10
1
Calls
$106K
Puts
$233K
Top Buyers
| 1 | +$639K | |
| 2 | +$144K | |
| 3 | +$70K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$42.1K |
| 5 |
State Street
Boston,
Massachusetts
|
+$33.3K |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$197K | |
| 3 | -$132K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$73K |
| 5 |
VF
Virtu Financial
New York
|
-$54.1K |